Business
Perimeter Announces Closing of Prospectus Offering
Perimeter Announces Closing of Prospectus Offering Canada NewsWire /NOT FOR D...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n\n\n\n Perimeter Announces Closing of Prospectus Offering\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN\n \n THE UNITED STATES\n \n /\n \n\n\n\n\n TORONTO\n \n and\n \n DALLAS\n \n\n ,\n \n\n June 3, 2025\n \n\n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (\"\n \n Perimeter\n \n \" or the \"\n \n Company\n \n \"), a commercial-stage medical technology company, is pleased to announce that it has completed its previously announced prospectus offering (the \"\n \n Offering\n \n \") of units of the Company (the \"\n \n Units\n \n \") and pre-funded units of the Company. The Offering was completed on a reasonable \"best efforts\" agency basis pursuant to an agency agreement (the \"\n \n Agency Agreement\n \n \") dated\n \n May 29, 2025\n \n between the Company and A.G.P. Canada Investments ULC (the \"\n \n Agent\n \n \"). Pursuant to the Offering, the Company has issued an aggregate of 10,432,801 Units at a price of\n \n $0.30\n \n per Unit (the \"\n \n Offering Price\n \n \") for aggregate gross proceeds of\n \n $3,129,840\n \n .\n \n\n\n\n\n\n\n\n\n Each Unit is comprised of one common share in the capital of the Company (each a \"\n \n Common Share\n \n \") and one Common Share purchase warrant (each a \"\n \n Warrant\n \n \"). Each Warrant entitles the holder to acquire an additional Common Share for a period of 60 months, at an exercise price of\n \n $0.35\n \n .\n \n\n Pursuant to the terms of the Agency Agreement, the Agent was entitled to receive a cash fee equal to 7.0% of the gross proceeds raised under the Offering, and compensation options equal to 5.0% of the aggregate number of Units issued under the Offering (the \"\n \n Compensation Options\n \n \"), with a reduced cash commission of 3.5% and Compensation Options equal to 2.5% payable in respect of Units sold to certain purchasers on a president's list. In addition, the Agent will receive no cash commission or Compensation Options with ...